Unlocking the Potential of Ribosomal Protein S2 Pseudogene 12 as a Drug Target and Biomarker

Target Name: RPS2P12

NCBI ID: G650901

RPS2P12

Other Name(s): Ribosomal protein S2 pseudogene 12 | RPS2_2_35 | ribosomal protein S2 pseudogene 12

Unlocking the Potential of Ribosomal Protein S2 Pseudogene 12 as a Drug Target and Biomarker

Introduction

Ribosomal protein S2 pseudogene 12 (RPS2P12) is a non-coding RNA molecule that plays a crucial role in the regulation of protein synthesis in eukaryotic cells. RPS2P12 is a key component of the ribosome, which is responsible for synthesizing proteins from amino acids. Mutations in RPS2P12 have been linked to various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

Despite the significant impact of RPS2P12 on protein synthesis, the study of its functions and potential as a drug target or biomarker remains an ongoing challenge. This article will explore the biology of RPS2P12, its functions in cell signaling and regulation, and its potential as a drug target.

The biology of RPS2P12

RPS2P12 is a 24.3 kb RNA molecule that contains 136 amino acid residues. It is predominantly expressed in the nucleus and cytoplasm of eukaryotic cells. RPS2P12 is composed of two distinct domains: a N-terminal domain and a C-terminal domain.

The N-terminal domain is characterized by a single amino acid residue at position -9, which is a conserved site that is involved in the formation of a hydrogen bond with the lysine residue on the 尾2 subunit of the ribosome. also contains a single amino acid residue at position -10, which is involved in the formation of a hydrogen bond with the arginine residue on the 尾3 subunit of the ribosome.

The C-terminal domain is characterized by a unique amino acid sequence that includes a conserved GCA repeated sequence, a conserved Asp residue, and a unique amino acid residue at position -21. The C-terminal domain also includes a single amino acid residue at position -22, which is involved in the formation of a hydrogen bond with the serine residue on the 尾2 subunit of the ribosome.

Functions of RPS2P12

Several studies have investigated the functions of RPS2P12. These studies have demonstrated that RPS2P12 plays a critical role in the regulation of protein synthesis in eukaryotic cells.

1. Ribosomal biosynthesis and protein synthesis: RPS2P12 is a key component of the ribosome, which is responsible for synthesizing proteins from amino acids. Mutations in RPS2P12 have been linked to various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

2. Cell signaling and regulation: RPS2P12 is involved in various signaling pathways in eukaryotic cells. For instance, RPS2P12 has been shown to be involved in the regulation of the cell cycle, cell growth, and apoptosis.

3. DNA replication and repair: RPS2P12 is also involved in the regulation of DNA replication and repair. Mutations in RPS2P12 have been linked to various diseases, including cancer, which suggests that RPS2P12 plays a critical role in the regulation of DNA replication and repair.

Potential as a drug target or biomarker:

The potential of RPS2P12 as a drug target or biomarker is high due to its involvement in various signaling pathways and its unique amino acid sequence. Several studies have shown that RPS2P12 can be targeted by small molecules, including inhibitors of tyrosine kinase activity and inhibitors of protein synthesis.

In addition, RPS2P12 has also been shown to be involved in the regulation of protein

Protein Name: Ribosomal Protein S2 Pseudogene 12

The "RPS2P12 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPS2P12 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets